Miles L A, Greengard J S, Griffin J H
Thromb Res. 1983 Feb 15;29(4):407-17. doi: 10.1016/0049-3848(83)90244-x.
In order to compare the relative potencies of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase as plasminogen activators, plasminogen activation by these proteins was studied using a radiolabeled fibrin plate assay. Urokinase was approximately 20,000 times more active than kallikrein or Factor XIa and 300,000 times more active than beta-Factor XIIa. Kallikrein and Factor XIa were approximately equal in plasminogen activator activity and were 20 times more potent than beta-Factor XIIa.
为了比较血浆激肽释放酶、β-因子XIIa、因子XIa和尿激酶作为纤溶酶原激活剂的相对效价,使用放射性标记纤维蛋白平板分析法研究了这些蛋白质对纤溶酶原的激活作用。尿激酶的活性比激肽释放酶或因子XIa高约20000倍,比β-因子XIIa高300000倍。激肽释放酶和因子XIa的纤溶酶原激活剂活性大致相等,比β-因子XIIa强20倍。